Amneal accelerates distribution and production of Hydroxychloroquine Sulfate to meet potential needs of COVID-19 patients nationwide

This article was originally published here

Amneal is ramping up production of hydroxychloroquine sulfate at several of its manufacturing sites and expects to produce approximately 20 million tablets between now and mid-April. Those tablets

The post Amneal accelerates distribution and production of Hydroxychloroquine Sulfate to meet potential needs of COVID-19 patients nationwide appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply